International Journal of Women's Health Dovepress Hyperglycemia in Pregnancy: Prevalence, Impact, and Management Challenges

hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms Abstract: Gestational diabetes mellitus (GDM) is one of the most common medical conditions in pregnancy, and the prevalence is growing with increasing rates of women of advanced age becoming pregnant and the increasing prevalence of maternal obesity and inactivity. GDM is associated with an increased risk of maternal and infant short-and long-term ill-health. There is a positive linear association between increasing maternal glucose at oral glucose tolerance testing and risk of important perinatal outcomes, including cesarean section, large for gestational age, and infant adiposity. A " step-up " approach, where diet and lifestyle information is provided followed by pharmacological interventions as required to control and reduce hyperglycemia, is effective at reducing the risk of macrosomia, but treatment of GDM will increase demand on health services. There is limited evidence to suggest which identification strategy is best or what thresholds should be used to diagnose GDM or what the effects of different diagnostic strategies have on short-or long-term maternal and offspring outcomes. Trials of interventions in pregnancy aimed at preventing GDM have not demonstrated a benefit; therefore, trials are needed to evaluate interventions aimed at optimizing the health of all women of childbearing age, outside of pregnancy. A consistent, evidence-based, sustained approach to supporting women to live healthily, including the achievement of a normal body mass index before and after pregnancy, is urgently needed.

[1]  A. Lee-Parritz,et al.  Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes , 2021, 50 Studies Every Obstetrician-Gynecologist Should Know.

[2]  D. Lawlor,et al.  Different strategies for diagnosing gestational diabetes to improve maternal and infant health. , 2017, The Cochrane database of systematic reviews.

[3]  P. Middleton,et al.  Progressing towards standard outcomes in gestational diabetes Cochrane reviews and randomised trials , 2016, The Australian & New Zealand journal of obstetrics & gynaecology.

[4]  F. Wolf,et al.  Standards of Medical Care in Diabetes—2016 Abridged for Primary Care Providers , 2016, Clinical Diabetes.

[5]  Debbie A Lawlor,et al.  Association between hyperglycaemia and adverse perinatal outcomes in south Asian and white British women: analysis of data from the Born in Bradford cohort , 2015, The lancet. Diabetes & endocrinology.

[6]  Jane Wardle,et al.  Effect of a behavioural intervention in obese pregnant women (the UPBEAT study): a multicentre, randomised controlled trial. , 2015, The lancet. Diabetes & endocrinology.

[7]  David E Newby,et al.  Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial , 2015, The lancet. Diabetes & endocrinology.

[8]  Eran Hadar,et al.  The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care # , 2015, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[9]  Nasim Karim,et al.  Metformin versus insulin treatment in gestational diabetes in pregnancy in a developing country: a randomized control trial. , 2015, Diabetes research and clinical practice.

[10]  U. Linnenkamp,et al.  Global estimates of the prevalence of hyperglycaemia in pregnancy. , 2014, Diabetes research and clinical practice.

[11]  F. Malone,et al.  Changing trends in diabetes mellitus in pregnancy , 2014, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[12]  Lisa Hartling,et al.  Benefits and Harms of Treating Gestational Diabetes Mellitus: A Systematic Review and Meta-analysis for the U.S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research , 2013, Annals of Internal Medicine.

[13]  M. Zugaib,et al.  Randomized trial of metformin vs insulin in the management of gestational diabetes. , 2013, American journal of obstetrics and gynecology.

[14]  F. Dunne,et al.  Applying Current Screening Tools for Gestational Diabetes Mellitus to a European Population: Is It Time for Change? , 2013, Diabetes Care.

[15]  F. R. Sharbaf,et al.  Metformin compared with insulin in the management of gestational diabetes mellitus: a randomized clinical trial. , 2012, Diabetes research and clinical practice.

[16]  Cheryl Steele,et al.  Women’s experiences of factors that facilitate or inhibit gestational diabetes self-management , 2012, BMC Pregnancy and Childbirth.

[17]  A. Dyer,et al.  Frequency of Gestational Diabetes Mellitus at Collaborating Centers Based on IADPSG Consensus Panel–Recommended Criteria , 2012, Diabetes Care.

[18]  M. Savvidou,et al.  An analysis of the interrelationship between maternal age, body mass index and racial origin in the development of gestational diabetes mellitus , 2012, BJOG : an international journal of obstetrics and gynaecology.

[19]  T. Ebeling,et al.  Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study , 2011, BJOG : an international journal of obstetrics and gynaecology.

[20]  R. Holt,et al.  The implications of the new International Association of Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria for gestational diabetes , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[21]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[22]  P. Middleton,et al.  Screening and subsequent management for gestational diabetes for improving maternal and infant health. , 2010, The Cochrane database of systematic reviews.

[23]  A. Dyer,et al.  International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy , 2010, Diabetes Care.

[24]  H. Bastian,et al.  Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[25]  Dwight J Rouse,et al.  A multicenter, randomized trial of treatment for mild gestational diabetes. , 2009, The New England journal of medicine.

[26]  J. Dungan,et al.  Hyperglycemia and Adverse Pregnancy Outcomes , 2009 .

[27]  G. Booth,et al.  Increased Risk of Cardiovascular Disease in Young Women Following Gestational Diabetes Mellitus , 2008, Diabetes Care.

[28]  Wanzhen Gao,et al.  Metformin versus insulin for the treatment of gestational diabetes. , 2008, The New England journal of medicine.

[29]  A. Ferrara Increasing Prevalence of Gestational Diabetes Mellitus , 2007, Diabetes Care.

[30]  K. Schwartz,et al.  Missed opportunities for type 2 diabetes mellitus screening among women with a history of gestational diabetes mellitus. , 2006, American journal of public health.

[31]  Anila Verma,et al.  Metabolic Syndrome in Childhood: Association With Birth Weight, Maternal Obesity, and Gestational Diabetes Mellitus , 2005, Pediatrics.

[32]  Catherine Kim,et al.  Gestational diabetes and the incidence of type 2 diabetes: a systematic review. , 2002, Diabetes care.

[33]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002, The New England journal of medicine.

[34]  P. Scanlon,et al.  Universal vs. risk factor‐based screening for gestational diabetes mellitus: detection rates, gestation at diagnosis and outcome , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[35]  J. Oats,et al.  Gestational diabetes mellitus ‐ management guidelines: The Australasian Diabetes in Pregnancy Society , 1998, The Medical journal of Australia.

[36]  S. O’Rahilly,et al.  An audit of a comprehensive screening programme for diabetes in pregnancy , 1998 .

[37]  E. Koukkou,et al.  Difference in prevalence of gestational diabetes and perinatal outcome in an innercity multiethnic London population. , 1995, European journal of obstetrics, gynecology, and reproductive biology.

[38]  D. Johnston,et al.  High Prevalence of Gestational Diabetes in Women from Ethnic Minority Groups , 1992, Diabetic medicine : a journal of the British Diabetic Association.

[39]  D. Coustan,et al.  Criteria for screening tests for gestational diabetes. , 1982, American journal of obstetrics and gynecology.

[40]  Classification and Diagnosis of Diabetes Mellitus and Other Categories of Glucose Intolerance , 1979, Diabetes.

[41]  M. Kennelly,et al.  The impact of new national guidelines on screening for gestational diabetes mellitus. , 2013, Irish medical journal.

[42]  Nasim Karim,et al.  Metformin prevents macrosomia and neonatal morbidity in gestational diabetes , 2012 .

[43]  P. Catalano,et al.  Association of existing diabetes, gestational diabetes and glycosuria in pregnancy with macrosomia and offspring body mass index, waist and fat mass in later childhood: findings from a prospective pregnancy cohort , 2009, Diabetologia.

[44]  A. Burden,et al.  Glucose tolerance during pregnancy in Asian women. , 1989, Diabetes research and clinical practice.

[45]  C. Mahan,et al.  CRITERIA FOR THE ORAL GLUCOSE TOLERANCE TEST IN PREGNANCY. , 1964, Diabetes.